Search research articles
Contact Us
Filters
Showing results (1-10 of 97) with videos related to
Page
of 10
Sort By:
Breast Cancer Research : BCR
|
January 9, 2009
Integration of endocrine therapy with targeted agents
Stephen R D Johnston
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
March 25, 2010
New strategies in estrogen receptor-positive breast cancer
Stephen R D Johnston
Idrugs : the Investigational Drugs Journal
|
June 6, 2003
BMS-214662 (Bristol-Myers Squibb)
Stephen R D Johnston
The Lancet. Oncology
|
March 25, 2014
Can NOAH guide us to improved survival in breast cancer?
Stephen R D Johnston
Annals of Palliative Medicine
|
January 30, 2023
Adjuvant CDK4/6 inhibitors: can they improve clinical outcomes in hormone receptor-positive (HR+) early breast cancer?
Stephen R D Johnston
European Journal of Cancer (Oxford, England : 1990)
|
September 28, 2011
The role of chemotherapy and targeted agents in patients with metastatic breast cancer
Stephen R D Johnston
European Journal of Cancer (Oxford, England : 1990)
|
September 28, 2011
Chairperson's introduction: Despite significant advances in the diagnosis and treatment of breast cancer, approximately one third of patients still develop, and subsequently die from metastatic breast disease
Stephen R D Johnston
Breast Cancer Research and Treatment
|
October 19, 2010
Are we missing the mTOR target in breast cancer?
Stephen R D Johnston
Breast Cancer Research : BCR
|
July 1, 2005
Endocrinology and hormone therapy in breast cancer: selective oestrogen receptor modulators and downregulators for breast cancer - have they lost their way?
Stephen R D Johnston
Hematology/Oncology Clinics of North America
|
November 26, 2022
Adjuvant Systemic Therapy for Postmenopausal, Hormone Receptor-Positive Early Breast Cancer
Stephen R D Johnston
Page
of 10
Search research articles
Search
Showing results (1-10 of 97) with videos related to
Sort By:
Page
of 10
Breast Cancer Research : BCR
|
January 9, 2009
Integration of endocrine therapy with targeted agents
Stephen R D Johnston
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
March 25, 2010
New strategies in estrogen receptor-positive breast cancer
Stephen R D Johnston
Idrugs : the Investigational Drugs Journal
|
June 6, 2003
BMS-214662 (Bristol-Myers Squibb)
Stephen R D Johnston
The Lancet. Oncology
|
March 25, 2014
Can NOAH guide us to improved survival in breast cancer?
Stephen R D Johnston
Annals of Palliative Medicine
|
January 30, 2023
Adjuvant CDK4/6 inhibitors: can they improve clinical outcomes in hormone receptor-positive (HR+) early breast cancer?
Stephen R D Johnston
European Journal of Cancer (Oxford, England : 1990)
|
September 28, 2011
The role of chemotherapy and targeted agents in patients with metastatic breast cancer
Stephen R D Johnston
European Journal of Cancer (Oxford, England : 1990)
|
September 28, 2011
Chairperson's introduction: Despite significant advances in the diagnosis and treatment of breast cancer, approximately one third of patients still develop, and subsequently die from metastatic breast disease
Stephen R D Johnston
Breast Cancer Research and Treatment
|
October 19, 2010
Are we missing the mTOR target in breast cancer?
Stephen R D Johnston
Breast Cancer Research : BCR
|
July 1, 2005
Endocrinology and hormone therapy in breast cancer: selective oestrogen receptor modulators and downregulators for breast cancer - have they lost their way?
Stephen R D Johnston
Hematology/Oncology Clinics of North America
|
November 26, 2022
Adjuvant Systemic Therapy for Postmenopausal, Hormone Receptor-Positive Early Breast Cancer
Stephen R D Johnston
Page
of 10